海森药业
(001367)
| 流通市值：7.37亿 | | | 总市值：28.91亿 |
| 流通股本：2615.47万 | | | 总股本：1.03亿 |
| 报告期 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 320,044,589.93 | 210,636,845.09 | 115,797,089.07 | 397,453,269.86 |
| 营业收入 | 320,044,589.93 | 210,636,845.09 | 115,797,089.07 | 397,453,269.86 |
| 二、营业总成本 | 220,992,411.05 | 145,296,234.7 | 77,405,038.6 | 277,738,367.43 |
| 营业成本 | 187,645,243.67 | 124,355,922.08 | 70,512,217.31 | 234,184,822.06 |
| 税金及附加 | 3,346,394.48 | 2,253,160.59 | 892,608.87 | 4,160,810.02 |
| 销售费用 | 8,665,871.18 | 6,004,616.21 | 1,713,996 | 10,461,387.56 |
| 管理费用 | 18,198,366.58 | 11,978,247.96 | 5,070,371.6 | 26,033,175.92 |
| 研发费用 | 17,831,319.55 | 11,588,314.81 | 4,279,248.99 | 18,841,608.1 |
| 财务费用 | -14,694,784.41 | -10,884,026.95 | -5,063,404.17 | -15,943,436.23 |
| 其中:利息费用 | 279,121.44 | 184,523.76 | 92,261.88 | 33,957.41 |
| 其中:利息收入 | 13,284,083 | 9,173,311.72 | 4,117,006.63 | 15,298,386.32 |
| 加:投资收益 | 174,271.23 | - | - | 319,693.15 |
| 资产处置收益 | - | - | - | -241,714.05 |
| 资产减值损失(新) | -592,848.05 | -545,506.23 | -306,990.35 | -2,438,513.67 |
| 信用减值损失(新) | 799,755.32 | 425,213.87 | -54,858.07 | -427,515.5 |
| 其他收益 | 2,196,462.59 | 2,152,303.34 | 1,068,696.45 | 5,048,012.88 |
| 营业利润平衡项目 | 0 | 0 | 0 | 0 |
| 四、营业利润 | 101,629,819.97 | 67,372,621.37 | 39,098,898.5 | 121,974,865.24 |
| 加:营业外收入 | 63,399.64 | 62,601.01 | 60,800.01 | 8,737.58 |
| 减:营业外支出 | 1,435,725.78 | 434,650.99 | 260,464.11 | 1,308,248.67 |
| 利润总额平衡项目 | 0 | 0 | 0 | 0 |
| 五、利润总额 | 100,257,493.83 | 67,000,571.39 | 38,899,234.4 | 120,675,354.15 |
| 减:所得税费用 | 13,307,355.25 | 8,960,123.44 | 5,514,464.27 | 16,007,885.59 |
| 六、净利润 | 86,950,138.58 | 58,040,447.95 | 33,384,770.13 | 104,667,468.56 |
| 持续经营净利润 | 86,950,138.58 | 58,040,447.95 | 33,384,770.13 | 104,667,468.56 |
| 归属于母公司股东的净利润 | 86,950,138.58 | 58,040,447.95 | 33,384,770.13 | 104,667,468.56 |
| (一)基本每股收益 | 0.86 | 0.58 | 0.49 | 1.68 |
| (二)稀释每股收益 | 0.86 | 0.58 | 0.49 | 1.68 |
| 九、综合收益总额 | 86,950,138.58 | 58,040,447.95 | 33,384,770.13 | 104,667,468.56 |
| 归属于母公司股东的综合收益总额 | 86,950,138.58 | 58,040,447.95 | 33,384,770.13 | 104,667,468.56 |
| 公告日期 | 2024-10-18 | 2024-08-28 | 2024-04-25 | 2024-04-23 |
| 审计意见(境内) | | | | 标准无保留意见 |